Transcripts Ocular Therapeutix, Inc.

Equities

OCUL

US67576A1007

Market Closed - Nasdaq Other stock markets 01:30:00 26/06/2024 am IST			5-day change	1st Jan Change
6.56 ^USD	+0.46%		+19.49%	+47.09%

20/06	Ocular Therapeutix Shares Rise After TD Cowen Upgrades Rating, Increases Price Target	MT
20/06	TD Cowen Upgrades Ocular Therapeutix to Buy From Hold, Adjusts Price Target to $11 From $7	MT

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Ocular Therapeutix, Inc. - Analyst/Investor Day	13/06
Transcript : Ocular Therapeutix, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 03:00 PM	16/05
Transcript : Ocular Therapeutix, Inc., Q3 2023 Earnings Call, Nov 07, 2023	08/11
Transcript : Ocular Therapeutix, Inc., Q2 2023 Earnings Call, Aug 07, 2023	08/23/08
Transcript : Ocular Therapeutix, Inc. - Special Call	12/23/12
Transcript : Ocular Therapeutix, Inc., Q1 2023 Earnings Call, May 08, 2023	09/23/09
Transcript : Ocular Therapeutix, Inc., Q4 2022 Earnings Call, Mar 06, 2023	07/23/07
Transcript : Ocular Therapeutix, Inc. - Special Call	13/23/13
Transcript : Ocular Therapeutix, Inc., Q3 2022 Earnings Call, Nov 07, 2022	08/22/08
Ocular Therapeutix, Inc. Provides Earnings Guidance for the Fiscal Year 2022	08/22/08	CI
Transcript : Ocular Therapeutix, Inc. - Special Call	27/22/27
Transcript : Ocular Therapeutix, Inc., Q2 2022 Earnings Call, Aug 08, 2022	09/22/09
Ocular Therapeutix, Inc. Provides Revenue Guidance for the Full Year 2022	09/22/09	CI
Transcript : Ocular Therapeutix, Inc., Q1 2022 Earnings Call, May 09, 2022	10/22/10
Ocular Therapeutix, Inc. Provides Earnings Guidance for the Full Year 2022	10/22/10	CI
Transcript : Ocular Therapeutix, Inc., Q4 2021 Earnings Call, Feb 28, 2022	01/22/01
Transcript : Ocular Therapeutix, Inc. - Special Call	06/21/06
Transcript : Ocular Therapeutix, Inc., Q3 2021 Earnings Call, Nov 08, 2021	09/21/09
Transcript : Ocular Therapeutix, Inc., Q2 2021 Earnings Call, Aug 09, 2021	10/21/10
Ocular Therapeutix, Inc. Provides Earnings Guidance for the Second Quarter Ended June 30, 2021	23/21/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Transcripts Ocular Therapeutix, Inc.

Equities

OCUL

US67576A1007

Transcripts

Filters